Healthcare

According to a market report by Lucintel, the future of the allergy diagnostics market looks promising with opportunities in diagnostic laboratories, hospitals, and academic research institutes. The global allergy diagnostics market is expected to reach an estimated $9.9 billion by 2028 with a CAGR of 10.7% from 2023 to 2028. The major drivers for this market are rising pollution level, increasing prevalence of allergies, and growing awareness among patients allergy about testing.



In this market, instruments, consumables, and services are the major segments by product. Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to increasing cases of allergies and growing need for rapid tests to diagnose allergic conditions.



Within this market, diagnostic laboratories are expected to remain the largest end use industry segment due to increasing preference of people for diagnosis from specialist and technological advancement in screening techniques that enable accurate diagnosis of diseases.



North America will remain the largest region due to growing awareness about allergy diagnostics and an increase in adoption of in-vitro blood tests.

bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, and Hitachi Chemical Diagnostics are the major suppliers in the global allergy diagnostics market.  



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global allergy diagnostics market by product, end use industry, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Allergy Diagnostics Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global allergy diagnostics market by product, end use industry, and region, as follows:

 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the allergy diagnostics market by product (instruments, consumables, and services), end use industry (diagnostic laboratories, hospitals, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?